List of Tables
Table 1. Pharmaceutical CDMO Solution Market Trends
Table 2. Pharmaceutical CDMO Solution Market Drivers & Opportunity
Table 3. Pharmaceutical CDMO Solution Market Challenges
Table 4. Pharmaceutical CDMO Solution Market Restraints
Table 5. Global Pharmaceutical CDMO Solution Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Pharmaceutical CDMO Solution Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Pharmaceutical CDMO Solution Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Pharmaceutical CDMO Solution Product Type
Table 9. Key Companies Time to Begin Mass Production of Pharmaceutical CDMO Solution
Table 10. Global Pharmaceutical CDMO Solution Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Solution as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Pharmaceutical CDMO Solution Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Pharmaceutical CDMO Solution Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Pharmaceutical CDMO Solution Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Pharmaceutical CDMO Solution Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Pharmaceutical CDMO Solution Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Pharmaceutical CDMO Solution Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Pharmaceutical CDMO Solution Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Pharmaceutical CDMO Solution Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Pharmaceutical CDMO Solution Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Pharmaceutical CDMO Solution Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Pharmaceutical CDMO Solution Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Pharmaceutical CDMO Solution Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Pharmaceutical CDMO Solution Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Pharmaceutical CDMO Solution Sales Value by Region (2019-2024) & (%)
Table 27. Global Pharmaceutical CDMO Solution Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Pharmaceutical CDMO Solution Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Pharmaceutical CDMO Solution Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Pharmaceutical CDMO Solution Sales Value, (2025-2030) & (US$ Million)
Table 31. Recipharm AB Basic Information List
Table 32. Recipharm AB Description and Business Overview
Table 33. Recipharm AB Pharmaceutical CDMO Solution Products, Services and Solutions
Table 34. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Recipharm AB (2019-2024)
Table 35. Recipharm AB Recent Developments
Table 36. Lonza Group Basic Information List
Table 37. Lonza Group Description and Business Overview
Table 38. Lonza Group Pharmaceutical CDMO Solution Products, Services and Solutions
Table 39. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Lonza Group (2019-2024)
Table 40. Lonza Group Recent Developments
Table 41. Catalent Basic Information List
Table 42. Catalent Description and Business Overview
Table 43. Catalent Pharmaceutical CDMO Solution Products, Services and Solutions
Table 44. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Catalent (2019-2024)
Table 45. Catalent Recent Developments
Table 46. Patheon (Thermo Fisher Scientific) Basic Information List
Table 47. Patheon (Thermo Fisher Scientific) Description and Business Overview
Table 48. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Products, Services and Solutions
Table 49. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Patheon (Thermo Fisher Scientific) (2019-2024)
Table 50. Patheon (Thermo Fisher Scientific) Recent Developments
Table 51. Siegfried AG Basic Information List
Table 52. Siegfried AG Description and Business Overview
Table 53. Siegfried AG Pharmaceutical CDMO Solution Products, Services and Solutions
Table 54. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Siegfried AG (2019-2024)
Table 55. Siegfried AG Recent Developments
Table 56. SGS Quay Pharmaceuticals Basic Information List
Table 57. SGS Quay Pharmaceuticals Description and Business Overview
Table 58. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Products, Services and Solutions
Table 59. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of SGS Quay Pharmaceuticals (2019-2024)
Table 60. SGS Quay Pharmaceuticals Recent Developments
Table 61. Curia Basic Information List
Table 62. Curia Description and Business Overview
Table 63. Curia Pharmaceutical CDMO Solution Products, Services and Solutions
Table 64. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Curia (2019-2024)
Table 65. Curia Recent Developments
Table 66. Thermo Fisher Scientific Basic Information List
Table 67. Thermo Fisher Scientific Description and Business Overview
Table 68. Thermo Fisher Scientific Pharmaceutical CDMO Solution Products, Services and Solutions
Table 69. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Thermo Fisher Scientific (2019-2024)
Table 70. Thermo Fisher Scientific Recent Developments
Table 71. Samsung Biologics Basic Information List
Table 72. Samsung Biologics Description and Business Overview
Table 73. Samsung Biologics Pharmaceutical CDMO Solution Products, Services and Solutions
Table 74. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Samsung Biologics (2019-2024)
Table 75. Samsung Biologics Recent Developments
Table 76. Fujifilm Diosynth Biotechnologies Basic Information List
Table 77. Fujifilm Diosynth Biotechnologies Description and Business Overview
Table 78. Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Products, Services and Solutions
Table 79. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Fujifilm Diosynth Biotechnologies (2019-2024)
Table 80. Fujifilm Diosynth Biotechnologies Recent Developments
Table 81. Societal CDMO Basic Information List
Table 82. Societal CDMO Description and Business Overview
Table 83. Societal CDMO Pharmaceutical CDMO Solution Products, Services and Solutions
Table 84. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Societal CDMO (2019-2024)
Table 85. Societal CDMO Recent Developments
Table 86. Aenova Group Basic Information List
Table 87. Aenova Group Description and Business Overview
Table 88. Aenova Group Pharmaceutical CDMO Solution Products, Services and Solutions
Table 89. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Aenova Group (2019-2024)
Table 90. Aenova Group Recent Developments
Table 91. Eurofins CDMO Basic Information List
Table 92. Eurofins CDMO Description and Business Overview
Table 93. Eurofins CDMO Pharmaceutical CDMO Solution Products, Services and Solutions
Table 94. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Eurofins CDMO (2019-2024)
Table 95. Eurofins CDMO Recent Developments
Table 96. Piramal Group Basic Information List
Table 97. Piramal Group Description and Business Overview
Table 98. Piramal Group Pharmaceutical CDMO Solution Products, Services and Solutions
Table 99. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Piramal Group (2019-2024)
Table 100. Piramal Group Recent Developments
Table 101. WuXi AppTec Group Basic Information List
Table 102. WuXi AppTec Group Description and Business Overview
Table 103. WuXi AppTec Group Pharmaceutical CDMO Solution Products, Services and Solutions
Table 104. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of WuXi AppTec Group (2019-2024)
Table 105. WuXi AppTec Group Recent Developments
Table 106. Fareva Basic Information List
Table 107. Fareva Description and Business Overview
Table 108. Fareva Pharmaceutical CDMO Solution Products, Services and Solutions
Table 109. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Fareva (2019-2024)
Table 110. Fareva Recent Developments
Table 111. Strides Pharma Science Basic Information List
Table 112. Strides Pharma Science Description and Business Overview
Table 113. Strides Pharma Science Pharmaceutical CDMO Solution Products, Services and Solutions
Table 114. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Strides Pharma Science (2019-2024)
Table 115. Strides Pharma Science Recent Developments
Table 116. Famar Health Care Service Basic Information List
Table 117. Famar Health Care Service Description and Business Overview
Table 118. Famar Health Care Service Pharmaceutical CDMO Solution Products, Services and Solutions
Table 119. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Famar Health Care Service (2019-2024)
Table 120. Famar Health Care Service Recent Developments
Table 121. WuXi Biologics Basic Information List
Table 122. WuXi Biologics Description and Business Overview
Table 123. WuXi Biologics Pharmaceutical CDMO Solution Products, Services and Solutions
Table 124. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of WuXi Biologics (2019-2024)
Table 125. WuXi Biologics Recent Developments
Table 126. Asymchem Basic Information List
Table 127. Asymchem Description and Business Overview
Table 128. Asymchem Pharmaceutical CDMO Solution Products, Services and Solutions
Table 129. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Asymchem (2019-2024)
Table 130. Asymchem Recent Developments
Table 131. Pfizer CentreOne Basic Information List
Table 132. Pfizer CentreOne Description and Business Overview
Table 133. Pfizer CentreOne Pharmaceutical CDMO Solution Products, Services and Solutions
Table 134. Revenue (US$ Million) in Pharmaceutical CDMO Solution Business of Pfizer CentreOne (2019-2024)
Table 135. Pfizer CentreOne Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Pharmaceutical CDMO Solution Downstream Customers
Table 139. Pharmaceutical CDMO Solution Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Pharmaceutical CDMO Solution Product Picture
Figure 2. Global Pharmaceutical CDMO Solution Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pharmaceutical CDMO Solution Sales Value (2019-2030) & (US$ Million)
Figure 4. Pharmaceutical CDMO Solution Report Years Considered
Figure 5. Global Pharmaceutical CDMO Solution Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical CDMO Solution Revenue in 2023
Figure 7. Pharmaceutical CDMO Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Active Pharmaceutical Ingredient (API) Manufacturing Picture
Figure 9. Finished Dosage Formulation (FDF) Development and Manufacturing Picture
Figure 10. Secondary Packaging Picture
Figure 11. Others Picture
Figure 12. Global Pharmaceutical CDMO Solution Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Pharmaceutical CDMO Solution Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Pharmaceutical Company
Figure 15. Product Picture of Biotechnology Company
Figure 16. Product Picture of Others
Figure 17. Global Pharmaceutical CDMO Solution Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Pharmaceutical CDMO Solution Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Pharmaceutical CDMO Solution Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Pharmaceutical CDMO Solution Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Pharmaceutical CDMO Solution Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Pharmaceutical CDMO Solution Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Pharmaceutical CDMO Solution Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Pharmaceutical CDMO Solution Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Pharmaceutical CDMO Solution Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Pharmaceutical CDMO Solution Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Pharmaceutical CDMO Solution Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Pharmaceutical CDMO Solution Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Pharmaceutical CDMO Solution Sales Value (%), (2019-2030)
Figure 30. United States Pharmaceutical CDMO Solution Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Pharmaceutical CDMO Solution Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Pharmaceutical CDMO Solution Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Pharmaceutical CDMO Solution Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Pharmaceutical CDMO Solution Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Pharmaceutical CDMO Solution Sales Value by Application (%), 2023 VS 2030
Figure 36. China Pharmaceutical CDMO Solution Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Pharmaceutical CDMO Solution Sales Value by Type (%), 2023 VS 2030
Figure 38. China Pharmaceutical CDMO Solution Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Pharmaceutical CDMO Solution Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Pharmaceutical CDMO Solution Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Pharmaceutical CDMO Solution Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Pharmaceutical CDMO Solution Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Pharmaceutical CDMO Solution Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Pharmaceutical CDMO Solution Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Pharmaceutical CDMO Solution Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Pharmaceutical CDMO Solution Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Pharmaceutical CDMO Solution Sales Value by Application (%), 2023 VS 2030
Figure 48. India Pharmaceutical CDMO Solution Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Pharmaceutical CDMO Solution Sales Value by Type (%), 2023 VS 2030
Figure 50. India Pharmaceutical CDMO Solution Sales Value by Application (%), 2023 VS 2030
Figure 51. Pharmaceutical CDMO Solution Industrial Chain
Figure 52. Pharmaceutical CDMO Solution Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
